Abstract. Proteoglycans (PGs) are a group of heavily glycosylated proteins that are present throughout the mammalian body and are involved in a wide variety of biological phenomena, including structural maintenance, tissue remodeling, molecular presentation, cell adhesion and signal transmission. Previous studies have revealed an increasing number of roles for PGs in human reproduction. Several PGs are currently utilized or regarded as biomarkers for the diagnosis of certain pathological uterine conditions associated with infertility and obstetrical complications. The aim of this review was to discuss the involvement of PGs in the human uterus in reproductive biology and pathophysiology.
Introduction
Proteoglycans (PGs) are a group of macromolecules which consist of one core protein and one or more covalently attached sulfated glycosaminoglycan (GAG) side chain(s). The PG core proteins are encoded by distinct genes and contain multiple functional domains that bind to and modulate a wide range of molecules, including chemokines, cytokines, growth factors, extracellular matrix (ECM) proteins, coagulation factors and lipid-metabolizing enzymes. The localization of PGs is attributed to the molecular and structural characteristics of their core proteins. GAGs consist of diversely epimerized/sulfated unbranched polysaccharide chains composed of 1,4-linked repeated disaccharide units. According to the combination of disaccharides, the sulfated GAG side chains are classified as chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS) and keratan sulfate (KS). The sulfation status of the GAG side chains in PGs varies with tissue type, location and age, which provides PGs with organ-dependent properties in molecular weight, structure and function (1) .
PGs are classified into two distinct types by their location in tissues: i) cell surface PGs and ii) ECM PGs (Table I ). The cell surface PGs include the syndecan and glypican families. Syndecans are a group of transmembrane HSPGs that interact with and regulate various soluble molecules. Glypicans are glycosylphosphatidylinositol-anchored HSPGs on the outer surface of the plasma membrane that regulate multiple intracellular signal pathways. The ECM PGs are subdivided into small leucine-rich PGs, the aggrecan/versican family and basement membrane PGs. Small leucine-rich PGs, which share repeats of leucine-rich structural motifs and cysteine residues, contribute to collagen fibrillogenesis and matrix assembly in the ECM. The aggrecan/versican family is a group of large PGs that engage in the maintenance of osmotic pressure and Diverse functions of uterine proteoglycans in human reproduction (Review) KOTARO (1) . PGs are broadly distributed in mammalian tissues. Previous studies have revealed the critical involvement of PGs in embryogenesis and organogenesis, particularly of cartilage, bone and eyes. Since the female genital organs exhibit marked physiological turnover and remodeling under the influence of ovarian steroids and pituitary hormones, PGs are thought to affect multiple facets of reproduction. Despite emerging data concerning the expression and functions of PGs in the genital organs in animal models, the exact roles of PGs in human reproduction have yet to be determined. The aim of this review was to discuss the current understanding of the correlation between PGs in the human uterus and reproduction and to provide insights into the possible future clinical uses of these studies.
PGs in human endometrium
Early studies focused on the expression of HSPGs in the endometrium and their effects on embryo implantation. In the human endometrium, HS is localized mainly to the basement membranes of the glandular epithelium, microvascular endothelium and stromal compartment and the ECM of the decidualized endometrium. HS expression in the endometrial glandular epithelium is constant throughout the menstrual cycle, while that in the endometrial microvascular endothelium acutely decreases during menstruation (2, 3) . By contrast, KS is absent in the proliferative phase endometrium, but appears in the surface/glandular epithelium and gland secretion during the secretory phase (4) . DS is localized to the whole endometrium and its expression level in microvascular endothelial cells and stromal fibroblasts increases following ovulation (5) . Previous studies have reported that CS is the predominant sulfated GAG species in the human endometrium. CS is localized to the stromal compartment of the cycling endometrium, particularly around arterioles and glands, with no marked menstrual cycledependent fluctuation (6) .
The production of certain PGs in the human endometrium is regulated by ovarian steroids. For instance, the HSPG thrombomodulin is among the genes induced in endometrial explant culture by in vitro progesterone stimulation (7) . It has been demonstrated that progesterone (alone or in combination with 17β-estradiol) enhances the expression of CS/HSPG serglycin and DS/CSPG biglycan and versican in endometrial endothelial cells (8) . Another potential regulator of endometrial PG synthesis is TGF-β3, which is capable of suppressing HSPG expression in endometrial stromal fibroblasts (9) .
As yet, no study has proven the indispensability of the endometrial PGs in embryo implantation. Mice lacking one of the PG core proteins or GAG-biosynthetic enzymes have been generated, but these mice develop normal primal embryo attachment sites on the decidualizing endometrium. As glypican-1 is a functional ligand for the prostaglandin-synthetic enzyme secretory phospholipase A2 group IIA, which is crucial for embryo attachment, endometrial glypican-1 was suggested as a candidate PG responsible for embryo implantation. The endometrial expression level of glypican-1, however, was similar in fertile women and patients with repeated implantation failure following in vitro fertilization-embryo transfer (10) . These findings are likely to result from the overlapping properties of PGs in embryo implantation.
By contrast, certain HSPGs and HS-synthetic enzymes are critical in early placentation. These topics are discussed below. Of note, the CS/DSPGs versican, biglycan and serglycin also potentially contribute to early placentation. Their expression level in the endometrial endothelium increases following ovulation (5, 11) . These endometrial endothelial PGs are thought to initiate the selective recruitment of circulating CD16(-) natural killer cells, which uniquely accumulate in the endometrial stromal compartment following ovulation (12) . These locally extravasated natural killer cells have been demonstrated to be essential for early placentation, as they secrete a wide variety of chemokines and angiogenic factors as well as monitoring trophoblast invasion (13).
Close association between miscarriage and deficiency in thrombomodulin and syndecan-4
Thrombomodulin was first cloned as a coagulation cascade co-factor expressed by intact endothelial cells. The membrane-bound form of thrombomodulin binds thrombin, which in turn catalyzes protein C and thrombin activatable fibrinolysis inhibitor into their mature forms and induces anti-inflammatory responses and cytoprotective signals in endothelial cells. In the murine uterus, thrombomodulin is expressed in the developing vasculature of embryos as well as in giant trophoblasts. Despite intact organogenesis and vasculogenesis, mice deficient in thrombomodulin exhibit embryonic lethality during mid to late gestation. These embryos exhibit consumptive coagulopathy during this period when massive hemorrhage occurs in the uterus, indicating the critical engagement of thrombomodulin in anticoagulant activity in the placenta (14) . In humans, the presence of thrombomodulin has been confirmed in decidual endothelial cells in the first trimester of pregnancy (15) . The results in the thrombomodulin gene knockout mice were confirmed by a prospective case-control study which demonstrated that the gene transcript expression level of thrombomodulin is lower in the placenta of unexplained recurrent miscarriage compared with that of normal pregnancy (16) .
Moreover, mice lacking the HSPG syndecan-4 gene are prone to form thrombi at the fetal-maternal interface, leading to miscarriage. The placental bed thrombosis in these mice is caused by the impaired bioactivity of anticoagulant factor anti-thrombin III, which is bound to and regulated by syndecan-4 (17). Syndecan-4 thus contributes to the maintenance of pregnancy by exerting coagulofibrinolytic activity disparate from thrombomodulin. In humans, syndecan-4 is localized to glandular epithelial cells in the cycling endometrium (18) , but its involvement in placentation remains to be established.
Syndecan-1 as a diagnostic biomarker for plasmacyte infiltrates in chronic endometritis
Syndecan-1 is involved in the presentation and modulation of ECM proteins (collagen types I, III and V, fibronectin and integrins), anticoagulation factors (thrombospondin and Table I . Expression profiling of PGs in the human non-pathological uterus. anti-thrombin III) and vascular endothelial growth factors. In the human non-pregnant uterus, syndecan-1 is localized to the cervix and endometrium, but not to the myometrium (18) (19) (20) (21) (22) . In the human endometrium, the expression level of syndecan-1 in endometrial epithelial cells is higher in the secretory phase than in the proliferative phase, while that in endometrial stromal fibroblasts is constant throughout the menstrual cycle. The localization patterns of syndecan-1 in the human endometrium are inconsistent between studies; some authors suggest that it is confined mainly to the apical and basolateral surface in glandular epithelial cells only during the secretory phase, while other authors claim that it has a wide distribution including surface/glandular epithelial cells and stromal fibroblasts (18, (20) (21) (22) . Such discrepancies appear to result from the differences in the antibodies used (i.e., mouse monoclonal antibody versus goat polyclonal antibody) and tissue preparation methods (i.e., frozen tissue versus fixed tissue).
Syndecan-1 has been established as a specific and sensitive biomarker for endometrial stromal plasmacyte infiltrates and is the most reliable histopathological landmark for chronic endometritis (18) . Immunohistochemistry for syndecan-1 improved the diagnostic accuracy of chronic endometritis, a potential cause of repeated embryo implantation failure (following in vitro fertilization and embryo transfer) and recurrent miscarriage (23) (24) (25) . In multiple myeloma, syndecan-1 inhibits tumor cell invasion by suppressing the bioactivity of matrix metalloproteinase-9, which is a protease that is highly expressed in the endometrium of infertile women (26) . It has been shown that syndecan-1-positive endometrial plasmacytes, unlike certain aggressive syndecan-1-negative endometrial B cells, remain in the stromal compartment without invading and destroying epithelial basement membranes (24) . These findings suggest the protective role of syndecan-1 in the maintenance of endometrial integrity against viral infections including human immunodeficiency virus-1, which initially attaches to endometrial epithelial cells via the cell surface HSPGs and frequently causes chronic endometritis (27).
DSPGs mediate ectopic growth and development of endometriosis
Endometriosis involves the ectopic growth and development of endometrial component cells. Ectopic endometrial tissues often deteriorate female fecundity by spreading over entire reproductive organs, ranging from the myometrium, peritoneum and ovaries to the Fallopian tubes. In contrast to eutopic endometrium being predominated by CS, DS is the major sulfated GAG observed in deeply infiltrating endometriotic lesions (28) .
DSPG versican is a gene that is highly expressed in the eutopic endometrium of endometriosis. In addition, the expression level of versican in the eutopic endometrial epithelium during the midsecretory phase is higher in severe cases of endometriosis than in mild cases (29, 30) . As versican is capable of stimulating cell proliferation and inhibiting apoptosis by binding ECM proteins on the cell surface, versican may contribute to the survival and increase in the number of eutopic endometrial cells in the ectopic microenvironment.
DS/CS-bearing PG CD44 forms a complex with another CSPG, CD74, and triggers the mitogen-activated protein kinase signaling cascades for cell survival. In endometriotic cells, macrophage migration-inhibitory factor has been demonstrated to bind the CD44/CD74 complex and activate chemokines and angiogenic factors in these cells, suggesting the involvement of this PG complex in the growth and development of endometriotic lesions (31).
PGs in human myometrium and cervix
The human myometrium and cervix contain a substantial amount of PGs. The main sulfated GAG species in the myometrium and cervix is DS, with fewer CS and HS (32, 33) . The GAG concentration in the myometrium markedly decreases during pregnancy, however, the proportion of the myometrial PGs does not vary during the menstrual cycle and gestational periods (34, 35) .
The predominant DSPG in the myometrium and cervix is decorin, which comprises two-thirds of the total myometrial PGs, although biglycan, versican and several HSPGs are also detectable (36) . The concentration of decorin in the cervix markedly decreases during term pregnancy, despite total PG synthesis increasing in this period (37) , indicating the involvement of decorin in cervical competency in early to mid gestation.
Syndecan-3 is localized not only to the plasma membrane of smooth muscle cells and myometrial vascular cells, but also to the ECM of the myometrium. 17β-Estradiol, but not progesterone, has been found to be able to stimulate the expression of the syndecan-3 gene transcript in the rat myometrium (37) . In contrast to decorin, syndecan-3 expression in the myometrium is patchy and weak in the non-pregnant condition, but becomes stronger with the establishment of pregnancy and increases towards term, particularly during labor (38) . These findings indicate that syndecan-3 is essential for active uterine contractions during parturition.
Contribution of fibromodulin, versican and decorin to structural maintenance and growth of uterine fibroids
Uterine fibroids (leiomyoma) are benign tumors that may affect human reproduction at various points, including implantation, placentation and fetal growth/positioning. Fibromodulin is a CS-bearing ECM PG with close homology to decorin and biglycan and contributes to the formation of collagen fibrillogenesis. During the proliferative phase of the menstrual cycle, fibromodulin is expressed in the uterine fibroid tissue at a two-to three-fold higher level than in the intact myometrium (39) . Similarly, decorin, versican, syndecan-4 and ECM protein-2 are overexpressed in fibroid tissues compared with the intact myometrium (40) . Decorin in the uterine fibroid is unique, as it contains longer GAG side chains and higher D-glucuronate/L-iduronate ratios compared with that in the intact myometrium (41, 42) . Increase in the size of the uterine fibroids results in the weaker activity of the sulfated GAG-degrading enzymes, including neutral endoglycosidase and acid endoglycosidase (43) . Notably, the administration of gonadotropin-releasing hormone analog, a therapeutic agent for uterine fibroids, was found to reduce fibromodulin expression in fibroid tissues to the levels in the intact myometrium (39), whereas all-trans retinoic acid, a promising agent for the treatment of fibroids, inhibited the proliferative activity of leiomyoma cells in a dose-dependent manner via the downregulation of versican expression (44) . These findings indicate that certain PGs function as scaffolds for the growth and development of fibroid tissues.
Furthermore, endometrium with uterine fibroids exhibits poor decidualization. One possible explanation for this impaired endometrial decidualization is that TGF-β3 secreted by uterine fibroids suppresses the thrombomodulin expression in endometrial stromal fibroblasts (9).
Low myometrial syndecan-3 expression in dystocia
As described in section 6, syndecan-3 is significant in the effective myometrial contractility during delivery (35) . This view is supported by the finding that the expression of the myometrial syndecan-3 gene transcript and protein is lower in women who experienced prolonged labor than in those with active labor, while there were no significant differences in myometrial syndecan-3 expression between non-pregnant women and those with active labor (38).
PGs in human placenta
The major PGs in the human placenta are HSPGs (syndecans and perlecan) and DSPGs (decorin and biglycan) (45) . Syndecan-1 is localized mainly to syncytiotrophoblasts of the placental villi (46) . Decorin is expressed in the stromal compartment surrounding the fetal capillaries of chorionic villi, while biglycan is distributed in endothelial cells and smooth muscle cells of fetal capillaries (47) . The expression level of syndecan-1 is upregulated in the process by which cytotrophoblasts differentiate into syncytiotrophoblasts (48) .
Similar to early pregnancy, placental PGs are also critical in the maintenance of placental vascular integrity during late pregnancy, via the anticoagulant activities of HS and DS, which stimulate the anticoagulant factors anti-thrombin III and heparin cofactor II, respectively (49) . Moreover, the results of in vitro experiments have shown that decorin inhibits the migration of human invading trophoblasts through insulinlike growth factor receptor I, while inhibiting the proliferation of these cells via receptors for epithelial growth factor or vascular endothelial growth factor (50), which are critical for hemo chorial placental formation.
Amniotic fluid perlecan and agrin as potential biomarkers for premature rupture of fetal membranes
Perlecan (also known as HSPG2) is a large basement membrane PG with five structural domains homologous to several growth factors. Perlecan is able to modulate various molecules involved in lipid metabolism, cell adhesion and angiogenesis.
In addition to the amnion and chorion, a dense accumulation of perlecan is observed in the central area of Nitabuch's layer, where chorionic villi anchor the decidua basalis. The expression level of placental perlecan is highest in early gestation and decreases towards term pregnancy (51) . Perlecan binds heparin/HS-interacting proteins on invading trophoblasts with high affinity and regulates their migration into the decidua (52) .
It has been found that the C-terminal laminin-like globular domain of perlecan is cleaved to form bioactive fragments by matrix metalloproteinases with angiostatic activity on endothelial cells. Proteomic analysis has found that these bioactive perlecan fragments are detectable specifically in the amniotic fluid of pregnant women who experienced the premature rupture of fetal membranes, as well as another basement membrane HSPG, agrin (53) . Premature rupture of fetal membranes is the pathological condition responsible for preterm deliveries and intrauterine infections, which cause neonatal morbidity and mortality. These basement membrane PGs are expected to be used as clinical biomarkers for the prediction of the premature rupture of fetal membranes.
Preventive role of syndecan-1 against pre-eclampsia
Pre-eclampsia is an obstetrical complication in which pregnant women develop hypertension with or without proteinuria. Pre-eclampsia causes serious maternal life-threatening conditions, including placental abruption, eclampsia and cerebral hemorrhage.
The expression level of HSPG syndecan-1 in syncytiotrophoblasts is reduced in patients with pre-eclampsia compared with those undergoing normal pregnancy (46) . In support of this finding, mice lacking the syndecan-1 gene are fertile but exhibit fetal growth restriction which is frequently complicated with pre-eclampsia (54, 55) . Mice lacking HS-3-O-sulfotransferase-1, the rate-limiting enzyme for anticoagulant HS synthesis, also exhibit fetal growth restriction without marked coagulopathy (56) . These results indicate the contribution of HSPGs to placental integrity via anticoagulant and alternative pathways. In humans, the expression level of decorin and CS/DS side chains in the term placenta is lower in women with pre-eclampsia compared with normal pregnancy (47, 57) . By contrast, the plasma concentration of HSPG thrombomodulin is significantly higher in women with pre-eclampsia than in those with normal pregnancy, supporting the hypothesis that endothelial injury is one of the mechanisms underlying pre-eclampsia (58) . Placental HSPGs and DSPGs may exert their functions for optimal vascular adaptation during gestation.
Upregulation of perlecan in villi of gestational diabetes mellitus
Placental villi in gestational diabetes mellitus express a higher level of perlecan and CS/DS than those in normal pregnancy (59) . In contrast to the findings that hyperglycemia suppressed perlecan and HS synthesis in aortic and glomerular endothelial cells, high glucose concentration and osmotic pressure were found to enhance in vitro perlecan expression in cytotrophoblasts (59) . The mechanism and significance for increased placental perlecan expression in gestational diabetes mellitus remain to be elucidated.
Elevated amniotic fluid lumican concentration in fetus with Turner syndrome
Lumican is highly expressed and its expression is elevated in certain types of cataract, one of the complications that occur in Turner syndrome. The lumican concentration has been shown to be higher in the amniotic fluid of Turner syndrome fetuses, although its correlation with postnatal cataract in this pathology is unknown (60).
Conclusions
There is a growing body of research which shows the essential roles of PGs in mammalian reproduction. The results of studies support the hypothesis that a deficiency in certain uterine PGs affects human fecundity. Several mice strains with deletion of the genes for certain PGs or GAG-biosynthetic enzymes undergo fetal mortality due to the lethal dysgenesis of the vital organs. The roles of these PGs in the human uterus remain largely unclear. Studies that use conditional knockout mice that specifically and transiently lose the endometrial gene expression of the PG core proteins or GAG-biosynthetic enzymes may provide more detailed information concerning the roles of individual PGs in reproduction.
